New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules, peptides and antibodies being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can.
| Cat.No. | Product Name | Activity |
| 4833 | Levonorgestrel | Synthetic progesterone analog |
| 4815 | 3-Cyano-7-ethoxycoumarin | Fluorescent cytochrome P450 substrate |
| 4547 | ACHP | Selective IKKα and IKKβ inhibitor |
| 4846 | Apicidin | Histone deacetylase inhibitor |
| 4804 | APETx2 | ASIC3 channel blocker |
| 4791 | Candesartan | AT1 receptor antagonist |
| 4779 | GRI 977143 | Selective LPA2 agonist; antiapoptotic |
| 4748 | ML 221 | Apelin receptor (APJ) antagonist |
| 4571 | A 867744 | Positive allosteric modulator of α7 nAChR |
| 4811 | TAT 14 | Nrf2 pathway activator; blocks Nrf2/Keap1 interaction |
| 4792 | Candesartan cilexetil | Prodrug of candesartan, an AT1 receptor antagonist |
| 4755 | Q94 hydrochloride | Negative allosteric modulator at PAR1 receptor |
| 4751 | FSLLRY-NH2 | PAR2 peptide antagonist |
| 4746 | ML SA1 | Activator of TRPML channels |
| 4744 | P11 | Potent antagonist of αvβ3-vitronectin interaction; antiangiogenic |
| 4677 | CYM 50260 | Potent and selective S1P4 agonist |
| 4638 | Pam2CSK4 Biotin | Biotinylated Pam2CSK4 (Cat. No. 4637) |
| 4636 | Pam3CSK4 Biotin | Biotinylated Pam3CSK4 (Cat. No. 4633) |
| 4345 | TC-C 14G | Potent, high affinity CB1 receptor inverse agonist |
| 4012 | SR 140333 | Potent NK1 receptor antagonist |
| 3920 | AMG 548 | Potent and selective p38α inhibitor |
| 3839 | HPI 1 | Inhibits Hedgehog signaling |
| 4541 | SGC 0946 | Highly potent and selective DOT1L inhibitor; cell permeable |